Posted by Michael Wonder on 16 Mar 2022
ICER publishes research protocol for assessing price increases of prescription drugs in California
16 March 2022 - Final assessment to be published on 13 October; drugs to be evaluated are those identified through California’s SB-17 drug price transparency report.
The ICER today posted a Protocol outlining the methods and procedures to be used in our analysis of the level of evidentiary support for high impact drug price increases in California during 2020.
